Sign in

CIK 0002070849 · Non-accelerated filer<br>Emerging growth company

BillionToOne, Inc.

Sign in to watch
Ticker
BLLN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811082020
Phone
650-460-2551
Business address
1035 O'BRIEN DRIVE, MENLO PARK, CA
  1. 4 Other disposition Director disposed of 505,925 shares (other)
  2. 4 Shares withheld for taxes Director gave up 436 shares (to pay taxes)
  3. 4 Planned sale SVP of Laboratory Operations sold 2,834 shares at $113.17 ($320,724)
  4. 4 Planned sale Chairman and CEO sold 30,335 shares at an average $109.93 ($3,334,642)
  5. 4 Planned sale Chief Technology Officer sold 20,000 shares at an average $109.24 ($2,184,854)
  6. 4 Planned sale Chairman and CEO sold 11,000 shares at $118.00 ($1,298,000)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Option exercise See Remarks acquired 2,000 shares (option exercise)
  9. 4 Planned sale Chairman and CEO sold 11,000 shares at an average $99.14 ($1,090,575)
  10. 4 Planned sale Chairman and CEO sold 19,334 shares at an average $94.31 ($1,823,450)
  11. 4 Option exercise See Remarks acquired 8,000 shares (option exercise)
  12. 4 Planned sale SVP of Laboratory Operations sold 2,834 shares at $105.15 ($297,995)
  13. 4 Planned sale Chief Technology Officer sold 20,000 shares at an average $108.15 ($2,162,950)
  14. 4 Planned sale Chairman and CEO sold 10,999 shares at $120.64 ($1,326,919)
  15. 4 Planned sale Chief Technology Officer sold 3,333 shares at $125.00 ($416,625)
  16. 4 Planned sale SVP of Laboratory Operations sold 1,416 shares at $120.00 ($169,920)
  17. 4 Planned sale SVP of Laboratory Operations sold 1,416 shares at $106.61 ($150,960)
  18. 4 Planned sale See Remarks sold 35,112 shares at an average $110.33 ($3,873,966)
  19. 4 Planned sale Chairman and CEO sold 30,331 shares at an average $99.91 ($3,030,444)
  20. 4 Gift Chief Product Officer gave 3,500 shares (gift)

Page 1 of 5 · 87 filings